750 related articles for article (PubMed ID: 19765815)
21. Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone.
Trigg JK; Mbwana H; Chambo O; Hills E; Watkins W; Curtis CF
Acta Trop; 1997 Feb; 63(2-3):185-9. PubMed ID: 9088432
[No Abstract] [Full Text] [Related]
22. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
[TBL] [Abstract][Full Text] [Related]
23. Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants.
Schreiber N; Kobbe R; Adjei S; Adjei O; Klinkert MQ; May J
Trop Med Int Health; 2007 Oct; 12(10):1157-63. PubMed ID: 17956497
[TBL] [Abstract][Full Text] [Related]
24. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
Macete E; Aide P; Aponte JJ; Sanz S; Mandomando I; Espasa M; Sigauque B; Dobaño C; Mabunda S; DgeDge M; Alonso P; Menendez C
J Infect Dis; 2006 Aug; 194(3):276-85. PubMed ID: 16826474
[TBL] [Abstract][Full Text] [Related]
25. Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi).
Kobbe R; Adjei S; Kreuzberg C; Kreuels B; Thompson B; Thompson PA; Marks F; Busch W; Tosun M; Schreiber N; Opoku E; Adjei O; Meyer CG; May J
Malar J; 2007 Dec; 6():163. PubMed ID: 18067679
[TBL] [Abstract][Full Text] [Related]
26. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Boudreau EF; Pang LW; Chaikummao S; Witayarut C
Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
[TBL] [Abstract][Full Text] [Related]
27. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
Mockenhaupt FP; Reither K; Zanger P; Roepcke F; Danquah I; Saad E; Ziniel P; Dzisi SY; Frempong M; Agana-Nsiire P; Amoo-Sakyi F; Otchwemah R; Cramer JP; Anemana SD; Dietz E; Bienzle U
Antimicrob Agents Chemother; 2007 Sep; 51(9):3273-81. PubMed ID: 17638703
[TBL] [Abstract][Full Text] [Related]
28. Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial.
Odhiambo FO; Hamel MJ; Williamson J; Lindblade K; ter Kuile FO; Peterson E; Otieno P; Kariuki S; Vulule J; Slutsker L; Newman RD
PLoS One; 2010 Apr; 5(4):e10016. PubMed ID: 20368815
[TBL] [Abstract][Full Text] [Related]
29. Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Grobusch MP; Lell B; Schwarz NG; Gabor J; Dornemann J; Potschke M; Oyakhirome S; Kiessling GC; Necek M; Langin MU; Klein Klouwenberg P; Klopfer A; Naumann B; Altun H; Agnandji ST; Goesch J; Decker M; Salazar CL; Supan C; Kombila DU; Borchert L; Koster KB; Pongratz P; Adegnika AA; Glasenapp Iv; Issifou S; Kremsner PG
J Infect Dis; 2007 Dec; 196(11):1595-602. PubMed ID: 18008242
[TBL] [Abstract][Full Text] [Related]
30. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
Cissé B; Sokhna C; Boulanger D; Milet J; Bâ el H; Richardson K; Hallett R; Sutherland C; Simondon K; Simondon F; Alexander N; Gaye O; Targett G; Lines J; Greenwood B; Trape JF
Lancet; 2006 Feb; 367(9511):659-67. PubMed ID: 16503464
[TBL] [Abstract][Full Text] [Related]
31. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
[TBL] [Abstract][Full Text] [Related]
32. A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania.
Mutabingwa TK; Maxwell CA; Sia IG; Msuya FH; Mkongewa S; Vannithone S; Curtis J; Curtis CF
Trans R Soc Trop Med Hyg; 2001; 95(4):433-8. PubMed ID: 11579891
[TBL] [Abstract][Full Text] [Related]
33. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
34. Intermittent preventive treatment for malaria in infants.
Esu EB; Oringanje C; Meremikwu MM
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Ezedinachi EN; Ekanem OJ; Chukwuani CM; Meremikwu MM; Ojar EA; Alaribe AA; Umotong AB; Haller L
Am J Trop Med Hyg; 1999 Jul; 61(1):114-9. PubMed ID: 10432067
[TBL] [Abstract][Full Text] [Related]
36. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Salako LA; Adio RA; Walker O; Sowunmi A; Stürchler D; Mittelholzer ML; Reber-Liske R; Dickschat U
Ann Trop Med Parasitol; 1992 Dec; 86(6):575-81. PubMed ID: 1304698
[TBL] [Abstract][Full Text] [Related]
37. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
38. Chlorproguanil-dapsone for treating uncomplicated malaria.
Bukirwa H; Garner P; Critchley J
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004387. PubMed ID: 15495106
[TBL] [Abstract][Full Text] [Related]
39. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G
Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children.
Greenwood BM; Greenwood AM; Smith AW; Menon A; Bradley AK; Snow RW; Sisay F; Bennett S; Watkins WM; N'Jie AB
Trans R Soc Trop Med Hyg; 1989; 83(2):182-8. PubMed ID: 2692227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
